Title : The Use of Sirolimus for Treatment of Orbital Lymphatic Malformations: A Systematic Review.

Pub. Date : 2020 May/Jun

PMID : 31990892






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Sirolimus, which inhibits mammalian target of rapamycin, a regulator of cell growth and vascular endothelial growth factor expression, has successfully treated systemic vascular malformations. Sirolimus vascular endothelial growth factor A Homo sapiens